During the past decade, Landeskrankenhaus Rankweil; Interne E conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Landeskrankenhaus Rankweil; Interne E" are "Breast Cancer" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Landeskrankenhaus Rankweil; Interne E" in a lesser frequency.

Most popular intervention types in "Landeskrankenhaus Rankweil; Interne E" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Chemotherapy (Induction Period)" (1 trials), "Pertuzumab" (1 trials), "Rituximab" (1 trials) and "Trastuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Landeskrankenhaus Rankweil; Interne E" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Landeskrankenhaus Rankweil; Interne E". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Landeskrankenhaus Rankweil; Interne E, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Landeskrankenhaus Rankweil; Interne E, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".